Three years into the ongoing COVID pandemic, an impassioned, growing group of patients and advocates for Long COVID and associated diseases (LCAD) is urging NIH to prioritize full funding of strategic research on therapeutics and to immediately halt plans to fund two problematic studies in the initial set of trials under the RECOVER Initiative.
Street Address
City, State, Zip
Phone Number
Building the power of chronically-ill and disabled people
Your Custom Text Here